1 hour ago
3 hours ago
In an interview, Bérard discusses population-based data showing no increased risk of major congenital malformations with first-trimester asthma controller use.
7 hours ago
In a Q&A with Dominic Sisti, Narva discusses ethics consult workflows, common conflicts, and lessons from complex ICU cases.
8 hours ago
Ravulizumab reduced proteinuria by week 10 and met the primary endpoint in the phase 3 I CAN trial in IgA nephropathy.
8 hours ago
There is an antifungal-resistant dermatophyte spreading globally, and experts are urging clinicians to become more aware.